Conclusion Patients with SMA, particularly those classified as type 2, showed a trend of improvement in lung function following nusinersen treatment.
← all excerpts
Effect of nusinersen on pulmonary function in children with spinal muscular atrophy in the plateau region: A pilot study.
1
—
—